These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 33386845)

  • 1. Stroke risk prediction in patients with atrial fibrillation with and without rheumatic heart disease.
    Benz AP; Healey JS; Chin A; Commerford P; Marsden T; Karthikeyan G; McIntyre WF; Wong JA; Damasceno A; Hohnloser SH; Oldgren J; Wallentin L; Ezekowitz MD; Eikelboom JW; Yusuf S; Connolly SJ
    Cardiovasc Res; 2022 Jan; 118(1):295-304. PubMed ID: 33386845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stroke and bleeding risk scores in patients with atrial fibrillation and valvular heart disease: evaluating 'valvular heart disease' in a nationwide cohort study.
    Lip GYH; Jensen M; Melgaard L; Skjøth F; Nielsen PB; Larsen TB
    Europace; 2019 Jan; 21(1):33-40. PubMed ID: 29986001
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stroke prevention strategies in patients with atrial fibrillation and heart valve abnormalities: perceptions of 'valvular' atrial fibrillation: results of the European Heart Rhythm Association Survey.
    Potpara TS; Lip GY; Larsen TB; Madrid A; Dobreanu D; Jędrzejczyk-Patej E; Dagres N;
    Europace; 2016 Oct; 18(10):1593-1598. PubMed ID: 27876696
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Temporal trends of atrial fibrillation and/or rheumatic heart disease-related ischemic stroke, and anticoagulant use in Chinese population: An 8-year study.
    Liu J; Wang Y; Guo W; Cheng Y; Zhang S; Wu B; Liu M
    Int J Cardiol; 2021 Jan; 322():258-264. PubMed ID: 32814110
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence, Characteristics, and Outcomes of Valvular Heart Disease in Patients With Atrial Fibrillation: Insights From the ORBIT-AF (Outcomes Registry for Better Informed Treatment for Atrial Fibrillation).
    Thomas KL; Jackson LR; Shrader P; Ansell J; Fonarow GC; Gersh B; Kowey PR; Mahaffey KW; Singer DE; Thomas L; Piccini JP; Peterson ED
    J Am Heart Assoc; 2017 Dec; 6(12):. PubMed ID: 29273635
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The value of the CHA2DS2-VASc score for refining stroke risk stratification in patients with atrial fibrillation with a CHADS2 score 0-1: a nationwide cohort study.
    Olesen JB; Torp-Pedersen C; Hansen ML; Lip GY
    Thromb Haemost; 2012 Jun; 107(6):1172-9. PubMed ID: 22473219
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence, risk determinants and consequences of atrial fibrillation in rheumatic heart disease: 6 years hospital based-Himachal Pradesh- Rheumatic Fever/Rheumatic Heart Disease (HP-RF/RHD) Registry.
    Negi PC; Sondhi S; Rana V; Rathoure S; Kumar R; Kolte N; Kumar R; Rao S; Diman A; Mahajan K; Dev M; Kandoria A; Ganju N; Bhardwaj R; Merwaha R; Sharma R; Asotra S
    Indian Heart J; 2018 Dec; 70 Suppl 3(Suppl 3):S68-S73. PubMed ID: 30595324
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of the CHA2DS2-VASc score with left atrial spontaneous echo contrast: a cross-sectional study of patients with rheumatic mitral stenosis in sinus rhythm.
    Belen E; Ozal E; Pusuroglu H
    Heart Vessels; 2016 Sep; 31(9):1537-43. PubMed ID: 26475711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dynamic Changes of CHA2DS2-VASc Score and the Risk of Ischaemic Stroke in Asian Patients with Atrial Fibrillation: A Nationwide Cohort Study.
    Yoon M; Yang PS; Jang E; Yu HT; Kim TH; Uhm JS; Kim JY; Pak HN; Lee MH; Lip GYH; Joung B
    Thromb Haemost; 2018 Jul; 118(7):1296-1304. PubMed ID: 29723875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of mitral regurgitation on stroke risk in patients with non-rheumatic atrial fibrillation.
    Raposeiras-Roubín S; Domínguez-Erquicia P; Abu-Assi E; Ledo-Piñeiro A; González-García A; Iglesias-Otero C; García-Campo E; Íñiguez-Romo A
    Arch Cardiovasc Dis; 2022; 115(8-9):448-456. PubMed ID: 36030169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of atrial fibrillation in patients with rheumatic mitral stenosis.
    Iung B; Leenhardt A; Extramiana F
    Heart; 2018 Jul; 104(13):1062-1068. PubMed ID: 29453328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of risk score (CHADS2 versus CHA2DS2-VASc) on long-term outcomes after atrial fibrillation ablation.
    Jacobs V; May HT; Bair TL; Crandall BG; Cutler M; Day JD; Weiss JP; Osborn JS; Muhlestein JB; Anderson JL; Mallender C; Bunch TJ
    Heart Rhythm; 2015 Apr; 12(4):681-6. PubMed ID: 25546809
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The INVICTUS rheumatic heart disease research program: Rationale, design and baseline characteristics of a randomized trial of rivaroxaban compared to vitamin K antagonists in rheumatic valvular disease and atrial fibrillation.
    Karthikeyan G; Connolly SJ; Ntsekhe M; Benz A; Rangarajan S; Lewis G; Yun Y; Sharma SK; Maklady F; Elghamrawy AE; Kazmi K; Cabral TTJ; Dayi H; Changsheng M; Gitura BM; Avezum A; Zuhlke L; Lwabi P; Haileamlak A; Ogah O; Chillo P; Paniagua M; ElSayed A; Dans A; Gondwe-Chunda L; Molefe-Baikai OJ; Gonzalez-Hermosillo JA; Hakim J; Damasceno A; Kamanzi ER; Musuku J; Davletov K; Connolly K; Mayosi BM; Yusuf S;
    Am Heart J; 2020 Jul; 225():69-77. PubMed ID: 32474206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contemporary management of atrial fibrillation and the predicted vs. absolute risk of ischaemic stroke despite treatment: a report from ESC-EHRA EORP-AF Long-Term General Registry.
    Ding WY; Blomström-Lundqvist C; Fauchier L; Marin F; Potpara TS; Boriani G; Lip GYH
    Europace; 2023 Feb; 25(2):277-282. PubMed ID: 36427202
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Meta-analysis of CHADS2 versus CHA2DS2-VASc for predicting stroke and thromboembolism in atrial fibrillation patients independent of anticoagulation.
    Zhu WG; Xiong QM; Hong K
    Tex Heart Inst J; 2015 Feb; 42(1):6-15. PubMed ID: 25873792
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CHA2DS2-VASc score for ischaemic stroke risk stratification in patients with chronic obstructive pulmonary disease with and without atrial fibrillation: a nationwide cohort study.
    Hu WS; Lin CL
    Europace; 2018 Apr; 20(4):575-581. PubMed ID: 28407109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence, clinical characteristics and outcomes of valvular atrial fibrillation in a cohort of African patients with acute heart failure: insights from the THESUS-HF registry.
    Sani MU; Davison BA; Cotter G; Mayosi BM; Edwards C; Ogah OS; Damasceno A; Ojji DB; Dzudie A; Mondo C; Kouam CK; Suliman A; Yonga G; Ba SA; Maru F; Alemayehu B; Sliwa K
    Cardiovasc J Afr; 2018; 29(3):139-145. PubMed ID: 30067272
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative Performance of ATRIA, CHADS2, and CHA2DS2-VASc Risk Scores Predicting Stroke in Patients With Atrial Fibrillation: Results From a National Primary Care Database.
    van den Ham HA; Klungel OH; Singer DE; Leufkens HG; van Staa TP
    J Am Coll Cardiol; 2015 Oct; 66(17):1851-9. PubMed ID: 26493655
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognosis in patients with atrial fibrillation and CHA2DS2-VASc Score = 0 in a community-based cohort study.
    Taillandier S; Olesen JB; Clémenty N; Lagrenade I; Babuty D; Lip GY; Fauchier L
    J Cardiovasc Electrophysiol; 2012 Jul; 23(7):708-13. PubMed ID: 22268375
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predicting the Outcomes of Acute Ischemic Stroke with Rheumatic Heart Disease: The Values of CHADS2, CHA2DS2-VASc, and HAS-BLED Scores.
    Liu J; Wang D; Tan G; Yuan R; Xu M; Xiong Y; Liu M
    J Stroke Cerebrovasc Dis; 2016 Mar; 25(3):722-6. PubMed ID: 26774873
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.